CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma

Published:2015-09 Issue:14 Volume:51 Page:1953-1961
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

An Huimin,Xu Le,Chang Yuan,Zhu Yu,Yang Yuanfeng,Chen Lian,Lin Zongming,Xu Jiejie

Funder

National Basic Research Program of China

National Natural Science Foundation of China

Program for New Century Excellent Talents in University

Shanghai Rising-Star Program

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2012

3. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy;Lam;J Urol,2005

4. Update on the medical treatment of metastatic renal cell carcinoma;Ravaud;Eur Urol,2008

5. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review;Sun;Eur Urol,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between IL8RB C1208T mutation and risk of cancer;Medicine;2022-02-25

2. Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility;Journal of Immunology Research;2021-10-14

3. Acute Kidney Injury–Induced Systemic Inflammation and Risk of Kidney Cancer Formation;Cancer Research;2021-05-14

4. Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma;Frontiers in Oncology;2021-04-28

5. Effect of interleukin-8 receptor B (IL8RB) rs1126579 C>T variation on the risk to cancer;Bioengineered;2021-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3